Published in
Wiley, Diabetes, Obesity and Metabolism, 9(20), p. 2210-2219, 2018
DOI: 10.1111/dom.13353
Links
Tools
Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials
Journal article published in 2018 by
Bo Ahrén 
,
Stephen L. Atkin ,
Guillaume Charpentier,
Mark L. Warren ,
John P. H. Wilding,
Sune Birch,
Anders Gaarsdal Holst ,
Lawrence A. Leiter
,
Stephen L. Atkin ,
Guillaume Charpentier,
Mark L. Warren ,
John P. H. Wilding,
Sune Birch,
Anders Gaarsdal Holst ,
Lawrence A. Leiter
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 